2024 Early Hearing Detection & Intervention Conference

March 17-19, 2024 • Denver, CO

<< BACK TO POSTERS

  |  Auditory Cortex Development in Children with Hearing Loss and Additional Disabilities.

Auditory Cortex Development in Children with Hearing Loss and Additional Disabilities.

Introduction: Approximately 20-40% of deaf or hard of hearing children have an additional disability (Cupples et al., 2018; Gallaudet Research Institute, 2011; Picard, 2004, Sharma, et al., 2013; Eisenberg, 2013; Birman, Elliott, & Gibson, 2012). However, data on the maturation of the auditory system in children with hearing loss and additional disabilities is scarce. This study explored developmental trajectories for auditory cortical development for children who have hearing loss and additional disabilities. Methods: Case studies of children with treated and untreated hearing loss and additional disabilities were examined. The P1 cortical auditory evoked potential (CAEP) biomarker assessed cortical auditory development. Results: Overall, P1 CAEPs can be a useful objective measure in children with multiple disabilities. Conclusion: Children with multiple disabilities may be difficult to test behaviorally. CAEP testing could allow for objective measurement of the effects of amplification on auditory cortical plasticity. Information such as this may be useful for guiding clinicians’ and parents’ expectations.

  • The participant will be able to describe outcomes in children with multiple disabilities
  • The participant will be able to identify how cortical auditory evoked potentials can be used in children with multiple disabilities
  • The participant will be able to identify how the P1 biomarker changes with amplification

Presentation:
This presentation has not yet been uploaded.

Handouts:
Handout is not Available

Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference


Presenters/Authors

Kayla Cormier (Primary Presenter,Author), University of Colorado Boulder, kayla.cormier@colorado.edu;
Kayla Cormier, AuD, CCC-A, is currently pursuing her PhD in Speech, Language, and Hearing Sciences from the University of Colorado Boulder and is a T-32 NIH fellow with the Otolaryngology department at the The University of Colorado Anschutz Medical School. Kayla received her AuD in May 2020 from Central Michigan University. Kayla’s research interests include the impact of hearing loss and hearing treatments on neuroplasticity. Her ultimate goal is to produce clinically relevant research that furthers the benefits we are able to provide to people with hearing loss.


ASHA DISCLOSURE:

Financial -
No relevant financial relationship exists.

Nonfinancial -
No relevant nonfinancial relationship exists.

AAA DISCLOSURE:

Financial -
No relevant financial relationship exists.

Nonfinancial -
No relevant nonfinancial relationship exists.

Carly Schimmel (Author), University of Colorado Boulder, carly.schimmel@colorado.edu;
Carly Schimmel is a PhD candidate at University of Colorado Boulder studying hearing science with additional concentrations in neuroscience and cognitive science. She has her AuD from University of Colorado Boulder and Bachelor's degree in neuroscience from Boston University.


ASHA DISCLOSURE:

Financial -
No relevant financial relationship exists.

Nonfinancial -
No relevant nonfinancial relationship exists.

AAA DISCLOSURE:

Financial -
No relevant financial relationship exists.

Nonfinancial -
No relevant nonfinancial relationship exists.

Anu Sharma (Author), University of Colorado Boulder, anu.sharma@colorado.edu;
Dr. Anu Sharma is professor in the Dept. of Speech Language and Hearing Science, a fellow at the Institute for Cognitive Science and Center for Neuroscience at University of Colorado at Boulder and adjunct professor in the Department of Otolaryngology and Audiology at the University of Colorado at Denver Medical School. Her research is focused on examining brain plasticity in children and adults with hearing loss who receive intervention with hearing aids and cochlear implants. Her research has been funded by the U.S. National Institutes of Health since 2001


ASHA DISCLOSURE:

Financial -

Nonfinancial -

AAA DISCLOSURE:

Financial -

Nonfinancial -